References
- Miyamori I, Yasuhara S, Takeda Y, et al. Effects of converting enzyme inhibition on split renal function in renovascular hypertension. Hypertension 1986; 8: 415
- Gavras H, Brunner H R, Turini G A, et al. Antihypertensive effect of oral converting-enzyme inhibitor SQ 14255 in man. New Eng J Med 1978; 298: 991
- Takeda R, Morimoto S, Uchida K, Miyamori I. Changes in plasma renin activity and plasma aldosterone in the induced attack of thyrotoxic periodic paralysis. Acta Endocrinol (copenh). 1978; 82: 715
- Textor S C, Novik A C, Mujais S K, et al. Responses of the stenosed and contralateral kidney to [Sar1, Thr8] AII in human renovascular hypertension. Hypertension 1978; 5: 796
- Textor S C, Tarazi R C, Novik A C, et al. Regulation of renal hemodynamics and glomerular filtration in patients with renovascular hypertension during converting enzyme inhibition by captopril. Am J Med 1984; 76(5B)29